Display Settings:

Format

Send to:

Choose Destination
Immunity. 2012 Nov 16;37(5):763-6. doi: 10.1016/j.immuni.2012.10.009.

Retroviral danger from within: TLR7 is in control.

Author information

  • 1Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany.

Abstract

In this issue of Immunity, Yu et al. (2012) outline a fascinating model in which TLR7-mediated antibody production acts as a dominant immunosurveillance mechanism against endogenous retroviruses (ERVs), with additional support of TLR3 and TLR9 that function to prevent ERV-mediated malignancy.

Copyright © 2012 Elsevier Inc. All rights reserved.

Comment on

PMID:
23159222
[PubMed]
Free full text

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk